T1	Limited_variation	0 19	Whereas GST-M1 null
T2	Pharmacodynamic_phenotype	34 59	cyclophosphamide efficacy
T3	Limited_variation	62 81	GST-P1 polymorphism
T4	Phenotype	114 150	susceptibility to further relapses .
R1	decreases	Arg1:T1	Arg2:T2
R2	increases	Arg1:T1	Arg2:T4
R3	isAssociatedWith	Arg1:T2	Arg2:T1
R4	isAssociatedWith	Arg1:T2	Arg2:T3
R5	increases	Arg1:T2	Arg2:T4
R6	influences	Arg1:T3	Arg2:T1
R7	increases	Arg1:T3	Arg2:T2
R8	increases	Arg1:T3	Arg2:T4
R9	increases	Arg1:T4	Arg2:T2
R10	increases	Arg1:T4	Arg2:T3
